Orchid Pharma (LUX:ORCHP) Institutional Ownership: 0.02% (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:ORCHP Orchid Pharma Ltd LUX:ORCHP
60 GF Score
Price $5.45
GF Value $4.38
! 10 Warning Signs
View Full Analysis

What is Orchid Pharma Institutional Ownership?

Orchid Pharma LUX:ORCHP 60 Institutional Ownership is 0.02% as of Jul. 23, 2026. GuruFocus rates LUX:ORCHP with a GF Score™ of 60/100 and a GF Value™ of $4.38. The stock has 10 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Orchid Pharma's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Orchid Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Orchid Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

Orchid Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Orchid Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orchid Pharma Institutional Ownership Chart

Orchid Pharma Historical Data

The historical data trend for Orchid Pharma can be seen below:

2006-09-30 2006-10-31 2006-11-30 2006-12-31 2007-01-31 2007-02-28 2007-03-31 2007-04-30 2007-05-31 2007-06-30
Institutional Ownership 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02
LUX:ORCHP
60GF Score
Orchid Pharma Ltd LUX:ORCHP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orchid Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
Orchid Pharma (LUX:ORCHP) has a Institutional Ownership of 0.02% as of Jul. 23, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Orchid Pharma and its competitors.
Is Orchid Pharma's Institutional Ownership too high?
Orchid Pharma's current Institutional Ownership is 0.02%. Overall, Orchid Pharma has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Orchid Pharma's Institutional Ownership compare to ZTS and UTHR?
Orchid Pharma's Institutional Ownership of 0.02% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Orchid Pharma and its competitors. Orchid Pharma's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orchid Pharma stock overvalued right now?
Orchid Pharma (LUX:ORCHP) has a current Institutional Ownership of 0.02%. The stock's GF Value™ is $4.38, compared to a current price of $5.45 — trading 24.4% above its estimated fair value. The current Institutional Ownership is 0.02%. Orchid Pharma's overall GF Score™ is 60/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Orchid Pharma (LUX:ORCHP), the current Institutional Ownership is 0.02% as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orchid Pharma (LUX:ORCHP) Overvalued in 2026?

Based on GuruFocus' analysis, Orchid Pharma stock appears to be overvalued. The current stock price of $5.45 is trading 24.4% above its estimated GF Value™ of $4.38.

Key valuation signals for LUX:ORCHP:

  • Institutional Ownership: 0.02%
  • GF Value™: $4.38 vs. price of $5.45 (24.4% above fair value)
  • GF Score™: 60/100 with 10 warning signs

No single metric tells the full story. See the LUX:ORCHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orchid Pharma Business Description

Address Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.
60GF Score

Get the complete analysis for LUX:ORCHP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$4.38
GF Value